Hemodynamic Profiles and Their Prognostic Relevance in Cardiac Amyloidosis
Open Access
- 11 April 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (4), 1093
- https://doi.org/10.3390/jcm9041093
Abstract
This study sought to characterize cardiac amyloidosis (CA) patients with respect to hemodynamic parameters and asses their prognostic impact in different CA cohorts. Intracardiac and pulmonary arterial pressures (PAPs) are among the strongest predictors of outcomes in patients with heart failure (HF). Despite that, the hemodynamic profiles of patients with CA and their relation to prognosis have rarely been investigated. Invasive hemodynamic, clinical, and laboratory assessment, as well as cardiac magnetic resonance imaging were performed in our CA cohort. A total of 61 patients, 35 (57.4%) with wild-type transthyretin amyloidosis (ATTRwt) and 26 (42.6%) with light-chain amyloidosis (AL) were enrolled. ATTRwt patients had lower N-terminal prohormone of brain natriuretic peptide values and were less frequently in New York Heart Association class ≥ III. Intracardiac and PAPs were elevated, but hemodynamic parameters did not differ between CA groups. Whereas in ATTRwt, the median mean PAP (hazard ratio (HR): 1.130, p = 0.040) and pulmonary vascular resistance (HR: 1.010, p = 0.046) were independent predictors of outcome, no hemodynamic parameter was associated with outcome in the AL group. Cardiac ATTRwt and AL patients feature elevated intracardiac and PAPs and show similar hemodynamic profiles. However, hemodynamic parameters are of greater prognostic relevance in ATTRwt, potentially providing a new therapeutic target.Keywords
This publication has 31 references indexed in Scilit:
- Clinical Features, Hemodynamics, and Outcomes of Pulmonary Hypertension Due to Chronic Heart Failure With Reduced Ejection FractionJACC: Heart Failure, 2013
- Riociguat for the Treatment of Chronic Thromboembolic Pulmonary HypertensionThe New England Journal of Medicine, 2013
- Riociguat for the Treatment of Pulmonary Arterial HypertensionThe New England Journal of Medicine, 2013
- Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain MeasurementsJournal of Clinical Oncology, 2012
- Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated methodJournal of Cardiovascular Magnetic Resonance, 2012
- American Society of Echocardiography Recommendations for Quality Echocardiography Laboratory OperationsJournal of the American Society of Echocardiography, 2011
- Systemic Cardiac AmyloidosesCirculation, 2009
- Relaxing the Rule of Ten Events per Variable in Logistic and Cox RegressionAmerican Journal of Epidemiology, 2006
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisAmerican Journal of Hematology, 2005
- Stain Technology: A Combined Elastic, Fibrin and Collagen StainStain Technology, 1987